CCM
BSX icon

Cinctive Capital Management’s Boston Scientific BSX Stock Holding History

Cinctive Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-200,000
Closed -$7.45M – 476
2022
Q2 		$7.45M Buy
200,000
+100,000
+100% +$4.07M 0.31% 104
2022
Q1 		$4.43M Buy
+100,000
New +$4.33M 0.16% 207

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cinctive Capital Management's BSX Position: Q1 2026 in Review

Cinctive Capital Management opened a new position in Boston Scientific (BSX) in Q1 2026: 20,462 shares worth $1.28M. The stake represents 0.08% of the portfolio and ranks #238 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in BSX as recently as Q3 2025.

Cinctive Capital Management first reported a position in BSX in Q4 2019 and has held it in 19 quarters since. The position peaked at $19.8M in Q1 2024. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Cinctive Capital Management held 20,462 shares of Boston Scientific worth $1.28M as of Q1 2026.
  • Boston Scientific was a new Cinctive Capital Management position in Q1 2026.
  • Boston Scientific made up 0.08% of Cinctive Capital Management's portfolio in Q1 2026, its #238 holding.
  • Cinctive Capital Management first reported a position in Boston Scientific in Q4 2019 and has held it in 19 quarters since.
  • Cinctive Capital Management's Boston Scientific position peaked at $19.8M in Q1 2024.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.